483
Oklahoma Blood Institute - IRBOklahoma Blood Institute - IRB – FDA 483, Feb 27, 2006
Record Details
An FDA inspection of Oklahoma Blood Institute - IRB in Oklahoma City revealed significant deficiencies in its Institutional Review Board operations. The firm failed to conduct research reviews at convened meetings, did not promptly notify investigators of approvals, and lacked proper record-keeping for consent documents and adverse event reports. These issues indicate a lack of adherence to established procedures for human subject protection.
- Office
- Dallas District Office
- Person
View Company Profile
ID · f9b97e87-a4ba-4409-bd99-688a79fc0bf9
Other documents for Oklahoma Blood Institute - IRB
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.